Cancer

Showing 15 posts of 1067 posts found.

Angelina Jolie image

‘Angelina effect’ sees BRCA tests soar in UK

September 19, 2014
Medical Communications, Research and Development, Sales and Marketing Cancer, angelina jolie, brac1, brad, breast, mastectomy

Referrals for testing for breast cancer risk more than doubled across the UK, after Oscar-winning American actress Angelina Jolie announced …

GSK melanoma drug sees quick NICE nod

September 18, 2014
Sales and Marketing Cancer, GSK, NICE, Tafinlar, Yervoy, dabrafenib, melanoma, skin cancer

NICE is recommending GlaxoSmithKline’s new melanoma treatment Tafinlar (dabrafenib) after the firm offered a discount for its medicine. In final …

Cancer drug gains first early UK access grant

September 17, 2014
Research and Development, Sales and Marketing Cancer, NICE, UK, keytruda, oncology, pin, promising

A new type of cell therapy for cancer has become the first to be deemed by the UK government as …

Celgene image

Celgene rebuffed by NICE over cancer drug

September 9, 2014
Sales and Marketing Abraxane, Cancer, Celgene, Gemzar, NICE, gemcitabine, nab-paclitaxel

In new draft guidance NICE says that Celgene’s Abraxane (nab-paclitaxel) taken with Lilly’s Gemzar (gemcitabine) should not be funded by …

NHS image

NHS cancer services not holding up, says report

September 8, 2014
Research and Development, Sales and Marketing CRUK, Cancer, NHS, UK, government, oncology

NHS cancer services are in urgent need of investment and review, according to a new report commissioned by Cancer Research …

Merck surprise winner in PD-1 race

September 5, 2014
Medical Communications, Research and Development, Sales and Marketing Cancer, Merck, melanoma, pd-1

Merck has become the first company to bring a new class of cancer drug to the US market after the …

Haslam image

NICE: Cancer Drugs Fund must use our processes

September 3, 2014
Medical Communications, Research and Development, Sales and Marketing CDF, Cancer, David Haslam, Kadcyla, NICE, Roche

NICE believes that the Cancer Drugs Fund should be aligned with its cost-effectiveness processes, after the government recently announced a …

Cancer image

Children’s cancer death rates drop

September 2, 2014
Medical Communications, Research and Development, Sales and Marketing CRUK, Cancer, Cancer Research UK, child, death rates

The rate of children dying from cancer has dropped by 22% in the last decade, according to new data published …

Ashya King image

NHS proton beam therapy refusal led to child patient disappearance

September 1, 2014
Sales and Marketing Ashya King, Cancer, NHS, proton beam

The parents of child cancer patient Ashya King say they took him from hospital because NHS doctors would not offer …

roche_glass_building

Roche pays $8.3bn for InterMune

August 26, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Genentech, IPF, Illumina, InterMune, Roche

Roche has stumped up $8.3 billion in cash to pay for US biotech firm InterMune and will gain access to …

cancer image

Top four cancer killer rates ‘fall by a third’

August 18, 2014
Research and Development, Sales and Marketing CRUK, Cancer, bowel, charity, lung, prostate, research

Death rates for breast, bowel, lung and prostate cancer combined have fallen by almost a third in the last 20 …

Zytiga image

Charities ‘disappointed’ in NICE and Janssen

August 15, 2014
Sales and Marketing Cancer, Janssen, NHS, NICE, Zytiga, prostate

The Institute of Cancer Research and Prostate Cancer UK are both urging NICE and Janssen to ‘get their act together’ …

amgen image

Amgen cancer drug fails key test

August 14, 2014
Sales and Marketing Amgen, Cancer, Kyprolis, myeloma

Amgen’s new rare cancer drug has failed in a late-stage trial just a year after the US biotech spent $10.4 …

Wikipedia image

Cancer Research UK appeals for clarity on Wikipedia

August 13, 2014
Medical Communications, Sales and Marketing Cancer, Cancer Research UK, wikimania, wikipedia

Cancer Research UK is calling upon the medical community to become more involved with Wikipedia to ensure better accuracy of …

Kadcyla packshot

Storm brewing over Roche cancer drug price

August 8, 2014
Medical Communications, Research and Development, Sales and Marketing Cancer, Haslam, Kadcyla, NICE, Roche, Yervoy, rejection

The Breakthrough Breast Cancer charity and England’s drug pricing watchdog NICE have both attacked Roche for not lowering the price …

The Gateway to Local Adoption Series

Latest content